** Medical device maker Autonomix Medical's shares more than double to $21.07, highest since July ** Company says its radiofrequency ablation procedure reduced pain in patients with pancreatic cancer
** Says all patients who responded to the procedure went to zero opioid use at 4-6 weeks post procedure
** Radiofrequency ablation is a minimally invasive procedure that uses radio waves to destroy abnormal cells or tissue and treat pain
** As of last close, stock down 92.4% since its IPO in January
(Reporting by Christy Santhosh) ((mailto:Christy.Santhosh@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.